How big is the market?

Q: How big is the market?

This medication is absorbed through the skin enters your bloodstream and helps your body reach normal testosterone levels.Report OverviewDue to the COVID19 pandemic and RussiaUkraine War Influence the global market for Product Name estimated at US million in the year 2022 is projected to reach a revised size of US million by 2028 growing at a CAGR of during the forecast period 20222028.The USA market for Transdermal Testosterone is estimated to increase from million in 2022 to reach million by 2028 at a CAGR of during the forecast period of 2023 through 2028.The China market for Transdermal Testosterone is estimated to increase from million in 2022 to reach million by 2028 at a CAGR of during the forecast period of 2023 .

BUY CHAPTERS

Global Transdermal Testosterone Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-20Q12037

Report

September 2022

Pages:119

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

TEVA

Perrigo

Endo Pharmaceuticals

Acerus Pharmaceuticals

Lupin Ltd

Dr. Reddy’s Laboratories

Upsher-Smith Laboratories

Allergan plc

Cipla Ltd

Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Transdermal Testosterone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Transdermal Testosterone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Transdermal Testosterone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Transdermal Testosterone include AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories and Allergan, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Transdermal Testosterone manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Transdermal Testosterone market. Further, it explains the major drivers and regional dynamics of the global Transdermal Testosterone market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

AbbVie

Teva

Perrigo

Endo Pharmaceuticals

Acerus Pharmaceuticals

Lupin

Dr. Reddy's Laboratories

Upsher-Smith Laboratories

Allergan

Cipla Inc.

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Transdermal Testosterone Segment by Type

Gel

Patch

Transdermal Testosterone Segment by Application

Primary Hypogonadism

Hypogonadotropic Hypogonadism

Late-Onset Hypogonadism

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Transdermal Testosterone market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Transdermal Testosterone, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Transdermal Testosterone, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Transdermal Testosterone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transdermal Testosterone sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Transdermal Testosterone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Transdermal Testosterone sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories and Allergan, etc.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Transdermal Testosterone Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Gel

1.2.3 Patch

1.3 Market Segment by Application

1.3.1 Global Transdermal Testosterone Market Share by Application (2017 VS 2021 VS 2028)

1.3.2 Primary Hypogonadism

1.3.3 Hypogonadotropic Hypogonadism

1.3.4 Late-Onset Hypogonadism

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Transdermal Testosterone Market Size (2017-2028)

2.1.1 Global Transdermal Testosterone Revenue (2017-2028)

2.1.2 Global Transdermal Testosterone Sales (2017-2028)

2.2 Global Transdermal Testosterone Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.2.1 Global Transdermal Testosterone Sales by Regions (2017-2022)

2.2.2 Global Transdermal Testosterone Revenue by Regions (2017-2022)

2.3 Global Transdermal Testosterone Market Size Forecast by Region

2.3.1 Global Transdermal Testosterone Sales Forecast by Region (2023-2028)

2.3.2 Global Transdermal Testosterone Revenue Forecast by Region (2023-2028)

2.4 Global Top Transdermal Testosterone Regions (Countries) Ranking by Market Size

2.5 Transdermal Testosterone Market Dynamics

2.5.1 Transdermal Testosterone Market Trends

2.5.2 Transdermal Testosterone Market Drivers

2.5.3 Transdermal Testosterone Market Challenges

2.5.4 Transdermal Testosterone Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Transdermal Testosterone Manufacturers by Sales (2017-2022)

3.1.1 Global Transdermal Testosterone Sales by Manufacturers (2017-2022)

3.1.2 Global Transdermal Testosterone Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global 5 and 10 Largest Manufacturers by Transdermal Testosterone Sales in 2021

3.2 Global Top Manufacturers Transdermal Testosterone by Revenue

3.2.1 Global Transdermal Testosterone Revenue by Manufacturers (2017-2022)

3.2.2 Top Transdermal Testosterone Manufacturers Covered: Ranking by Revenue

3.2.3 Global Transdermal Testosterone Revenue Share by Manufacturers (2017-2022)

3.2.4 Global Transdermal Testosterone Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Testosterone as of 2021)

3.4 Global Transdermal Testosterone Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Transdermal Testosterone Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Transdermal Testosterone Market

3.7 Key Manufacturers Transdermal Testosterone Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Transdermal Testosterone Market Size by Type

4.1 Global Transdermal Testosterone Historic Market Review by Type (2017-2022)

4.1.1 Global Transdermal Testosterone Sales Market Share by Type (2017-2022)

4.1.2 Global Transdermal Testosterone Revenue Market Share by Type (2017-2022)

4.1.3 Transdermal Testosterone Price by Type (2017-2022)

4.2 Global Transdermal Testosterone Market Estimates and Forecasts by Type (2023-2028)

4.2.1 Global Transdermal Testosterone Sales Forecast by Type (2023-2028)

4.2.2 Global Transdermal Testosterone Revenue Forecast by Type (2023-2028)

4.2.3 Transdermal Testosterone Price Forecast by Type (2023-2028)

5 Global Transdermal Testosterone Market Size by Application

5.1 Global Transdermal Testosterone Historic Market Review by Application (2017-2022)

5.1.1 Global Transdermal Testosterone Sales Market Share by Application (2017-2022)

5.1.2 Global Transdermal Testosterone Revenue Market Share by Application (2017-2022)

5.1.3 Transdermal Testosterone Price by Application (2017-2022)

5.2 Global Transdermal Testosterone Market Estimates and Forecasts by Application (2023-2028)

5.2.1 Global Transdermal Testosterone Sales Forecast by Application (2023-2028)

5.2.2 Global Transdermal Testosterone Revenue Forecast by Application (2023-2028)

5.2.3 Transdermal Testosterone Price Forecast by Application (2023-2028)

6 North America

6.1 North America Transdermal Testosterone Sales Breakdown by Company

6.1.1 North America Transdermal Testosterone Sales by Company (2017-2022)

6.1.2 North America Transdermal Testosterone Revenue by Company (2017-2022)

6.2 North America Transdermal Testosterone Market Size by Type

6.2.1 North America Transdermal Testosterone Sales by Type (2017-2028)

6.2.2 North America Transdermal Testosterone Revenue by Type (2017-2028)

6.3 North America Transdermal Testosterone Market Size by Application

6.3.1 North America Transdermal Testosterone Sales by Application (2017-2028)

6.3.2 North America Transdermal Testosterone Revenue by Application (2017-2028)

6.4 North America Transdermal Testosterone Market Size by Country

6.4.1 North America Transdermal Testosterone Sales by Country (2017-2028)

6.4.2 North America Transdermal Testosterone Revenue by Country (2017-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Transdermal Testosterone Sales Breakdown by Company

7.1.1 Europe Transdermal Testosterone Sales by Company (2017-2022)

7.1.2 Europe Transdermal Testosterone Revenue by Company (2017-2022)

7.2 Europe Transdermal Testosterone Market Size by Type

7.2.1 Europe Transdermal Testosterone Sales by Type (2017-2028)

7.2.2 Europe Transdermal Testosterone Revenue by Type (2017-2028)

7.3 Europe Transdermal Testosterone Market Size by Application

7.3.1 Europe Transdermal Testosterone Sales by Application (2017-2028)

7.3.2 Europe Transdermal Testosterone Revenue by Application (2017-2028)

7.4 Europe Transdermal Testosterone Market Size by Country

7.4.1 Europe Transdermal Testosterone Sales by Country (2017-2028)

7.4.2 Europe Transdermal Testosterone Revenue by Country (2017-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Transdermal Testosterone Sales Breakdown by Company

8.1.1 Asia Pacific Transdermal Testosterone Sales by Company (2017-2022)

8.1.2 Asia Pacific Transdermal Testosterone Revenue by Company (2017-2022)

8.2 Asia Pacific Transdermal Testosterone Market Size by Type

8.2.1 Asia Pacific Transdermal Testosterone Sales by Type (2017-2028)

8.2.2 Asia Pacific Transdermal Testosterone Revenue by Type (2017-2028)

8.3 Asia Pacific Transdermal Testosterone Market Size by Application

8.3.1 Asia Pacific Transdermal Testosterone Sales by Application (2017-2028)

8.3.2 Asia Pacific Transdermal Testosterone Revenue by Application (2017-2028)

8.4 Asia Pacific Transdermal Testosterone Market Size by Region

8.4.1 Asia Pacific Transdermal Testosterone Sales by Region

8.4.2 Asia Pacific Transdermal Testosterone Revenue by Region

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America Transdermal Testosterone Sales Breakdown by Company

9.1.1 Latin America Transdermal Testosterone Sales by Company (2017-2022)

9.1.2 Latin America Transdermal Testosterone Revenue by Company (2017-2022)

9.2 Latin America Transdermal Testosterone Market Size by Type

9.2.1 Latin America Transdermal Testosterone Sales by Type (2017-2028)

9.2.2 Latin America Transdermal Testosterone Revenue by Type (2017-2028)

9.3 Latin America Transdermal Testosterone Market Size by Application

9.3.1 Latin America Transdermal Testosterone Sales by Application (2017-2028)

9.3.2 Latin America Transdermal Testosterone Revenue by Application (2017-2028)

9.4 Latin America Transdermal Testosterone Market Size by Country

9.4.1 Latin America Transdermal Testosterone Sales by Country (2017-2028)

9.4.2 Latin America Transdermal Testosterone Revenue by Country (2017-2028)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Transdermal Testosterone Sales Breakdown by Company

10.1.1 Middle East and Africa Transdermal Testosterone Sales by Company (2017-2022)

10.1.2 Middle East and Africa Transdermal Testosterone Revenue by Company (2017-2022)

10.2 Middle East and Africa Transdermal Testosterone Market Size by Type

10.2.1 Middle East and Africa Transdermal Testosterone Sales by Type (2017-2028)

10.2.2 Middle East and Africa Transdermal Testosterone Revenue by Type (2017-2028)

10.3 Middle East and Africa Transdermal Testosterone Market Size by Application

10.3.1 Middle East and Africa Transdermal Testosterone Sales by Application (2017-2028)

10.3.2 Middle East and Africa Transdermal Testosterone Revenue by Application (2017-2028)

10.4 Middle East and Africa Transdermal Testosterone Market Size by Country

10.4.1 Middle East and Africa Transdermal Testosterone Sales by Country (2017-2028)

10.4.2 Middle East and Africa Transdermal Testosterone Revenue by Country (2017-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Company Profiles

11.1 AbbVie

11.1.1 AbbVie Corporation Information

11.1.2 AbbVie Overview

11.1.3 AbbVie Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.1.4 AbbVie Transdermal Testosterone Products and Services

11.1.5 AbbVie Transdermal Testosterone SWOT Analysis

11.1.6 AbbVie Recent Developments

11.2 Teva

11.2.1 Teva Corporation Information

11.2.2 Teva Overview

11.2.3 Teva Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.2.4 Teva Transdermal Testosterone Products and Services

11.2.5 Teva Transdermal Testosterone SWOT Analysis

11.2.6 Teva Recent Developments

11.3 Perrigo

11.3.1 Perrigo Corporation Information

11.3.2 Perrigo Overview

11.3.3 Perrigo Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.3.4 Perrigo Transdermal Testosterone Products and Services

11.3.5 Perrigo Transdermal Testosterone SWOT Analysis

11.3.6 Perrigo Recent Developments

11.4 Endo Pharmaceuticals

11.4.1 Endo Pharmaceuticals Corporation Information

11.4.2 Endo Pharmaceuticals Overview

11.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.4.4 Endo Pharmaceuticals Transdermal Testosterone Products and Services

11.4.5 Endo Pharmaceuticals Transdermal Testosterone SWOT Analysis

11.4.6 Endo Pharmaceuticals Recent Developments

11.5 Acerus Pharmaceuticals

11.5.1 Acerus Pharmaceuticals Corporation Information

11.5.2 Acerus Pharmaceuticals Overview

11.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.5.4 Acerus Pharmaceuticals Transdermal Testosterone Products and Services

11.5.5 Acerus Pharmaceuticals Transdermal Testosterone SWOT Analysis

11.5.6 Acerus Pharmaceuticals Recent Developments

11.6 Lupin

11.6.1 Lupin Corporation Information

11.6.2 Lupin Overview

11.6.3 Lupin Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.6.4 Lupin Transdermal Testosterone Products and Services

11.6.5 Lupin Transdermal Testosterone SWOT Analysis

11.6.6 Lupin Recent Developments

11.7 Dr. Reddy's Laboratories

11.7.1 Dr. Reddy's Laboratories Corporation Information

11.7.2 Dr. Reddy's Laboratories Overview

11.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.7.4 Dr. Reddy's Laboratories Transdermal Testosterone Products and Services

11.7.5 Dr. Reddy's Laboratories Transdermal Testosterone SWOT Analysis

11.7.6 Dr. Reddy's Laboratories Recent Developments

11.8 Upsher-Smith Laboratories

11.8.1 Upsher-Smith Laboratories Corporation Information

11.8.2 Upsher-Smith Laboratories Overview

11.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.8.4 Upsher-Smith Laboratories Transdermal Testosterone Products and Services

11.8.5 Upsher-Smith Laboratories Transdermal Testosterone SWOT Analysis

11.8.6 Upsher-Smith Laboratories Recent Developments

11.9 Allergan

11.9.1 Allergan Corporation Information

11.9.2 Allergan Overview

11.9.3 Allergan Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.9.4 Allergan Transdermal Testosterone Products and Services

11.9.5 Allergan Transdermal Testosterone SWOT Analysis

11.9.6 Allergan Recent Developments

11.10 Cipla Inc.

11.10.1 Cipla Inc. Corporation Information

11.10.2 Cipla Inc. Overview

11.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.10.4 Cipla Inc. Transdermal Testosterone Products and Services

11.10.5 Cipla Inc. Transdermal Testosterone SWOT Analysis

11.10.6 Cipla Inc. Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Transdermal Testosterone Value Chain Analysis

12.2 Transdermal Testosterone Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Transdermal Testosterone Production Mode & Process

12.4 Transdermal Testosterone Sales and Marketing

12.4.1 Transdermal Testosterone Sales Channels

12.4.2 Transdermal Testosterone Distributors

12.5 Transdermal Testosterone Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

AbbVie

TEVA

Perrigo

Endo Pharmaceuticals

Acerus Pharmaceuticals

Lupin Ltd

Dr. Reddy’s Laboratories

Upsher-Smith Laboratories

Allergan plc

Cipla Ltd

List of Tables

Table 1. Global Transdermal Testosterone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Gel

Table 3. Major Manufacturers of Patch

Table 4. Global Transdermal Testosterone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Transdermal Testosterone Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

Table 6. Global Transdermal Testosterone Sales by Region (2017-2022) & (K Units)

Table 7. Global Transdermal Testosterone Sales Market Share by Region (2017-2022)

Table 8. Global Transdermal Testosterone Revenue by Region (2017-2022) & (US$ Million)

Table 9. Global Transdermal Testosterone Revenue Market Share by Region (2017-2022)

Table 10. Global Transdermal Testosterone Sales Forecast by Region (2023-2028) & (K Units)

Table 11. Global Transdermal Testosterone Sales Market Share Forecast by Region (2023-2028)

Table 12. Global Transdermal Testosterone Revenue Forecast by Region (2023-2028) & (US$ Million)

Table 13. Global Transdermal Testosterone Revenue Market Share Forecast by Region (2023-2028)

Table 14. Top Transdermal Testosterone Regions (Countries) Ranking by Market Size (US$ Million) in 2021

Table 15. Transdermal Testosterone Market Trends

Table 16. Transdermal Testosterone Market Drivers

Table 17. Transdermal Testosterone Market Challenges

Table 18. Transdermal Testosterone Market Restraints

Table 19. Global Transdermal Testosterone Sales by Manufacturers (2017-2022) & (K Units)

Table 20. Global Transdermal Testosterone Sales Share by Manufacturers (2017-2022)

Table 21. Global Transdermal Testosterone Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 22. Ranking of Global Top Transdermal Testosterone Manufacturers by Revenue (US$ Million) in 2021

Table 23. Transdermal Testosterone Revenue Share by Manufacturers (2017-2022)

Table 24. Global Transdermal Testosterone Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Testosterone as of 2021)

Table 26. Key Manufacturers Transdermal Testosterone Average Selling Price (ASP) & (2017-2022) & (USD/Unit)

Table 27. Key Manufacturers Transdermal Testosterone Plants/Factories Distribution

Table 28. Key Manufacturers Transdermal Testosterone Area Served

Table 29. Date of Key Manufacturers Enter into Transdermal Testosterone Market

Table 30. Key Manufacturers Transdermal Testosterone Product Type

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Transdermal Testosterone Sales (K Units) by Type (2017-2022)

Table 33. Global Transdermal Testosterone Sales Share by Type (2017-2022)

Table 34. Global Transdermal Testosterone Revenue (US$ Million) Market Share by Type (2017-2022)

Table 35. Global Transdermal Testosterone Price (K Units) by Type (2017-2022)

Table 36. Global Transdermal Testosterone Sales (K Units) by Type (2023-2028)

Table 37. Global Transdermal Testosterone Sales Share by Type (2023-2028)

Table 38. Global Transdermal Testosterone Revenue (US$ Million) Market Share by Type (2023-2028)

Table 39. Global Transdermal Testosterone Revenue Share by Type (2023-2028)

Table 40. Global Transdermal Testosterone Price (K Units) by Type (2023-2028)

Table 41. Global Transdermal Testosterone Sales (K Units) by Application (2017-2022)

Table 42. Global Transdermal Testosterone Sales Share by Application (2017-2022)

Table 43. Global Transdermal Testosterone Revenue (US$ Million) Market Share by Application (2017-2022)

Table 44. Global Transdermal Testosterone Price (K Units) by Application (2017-2022)

Table 45. Global Transdermal Testosterone Sales (K Units) by Application (2023-2028)

Table 46. Global Transdermal Testosterone Sales Share by Application (2023-2028)

Table 47. Global Transdermal Testosterone Revenue (US$ Million) Market Share by Application (2023-2028)

Table 48. Global Transdermal Testosterone Revenue Share by Application (2023-2028)

Table 49. Global Transdermal Testosterone Price (K Units) by Application (2023-2028)

Table 50. North America Transdermal Testosterone Sales by Company (2017-2022) & (K Units)

Table 51. North America Transdermal Testosterone Sales Market Share by Company (2017-2022)

Table 52. North America Transdermal Testosterone Revenue by Company (2017-2022) & (US$ Million)

Table 53. North America Transdermal Testosterone Revenue Market Share by Company (2017-2022)

Table 54. North America Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 55. North America Transdermal Testosterone Sales by Type (2023-2028) & (K Units)

Table 56. North America Transdermal Testosterone Revenue by Type (2017-2022) & (US$ Million)

Table 57. North America Transdermal Testosterone Revenue by Type (2023-2028) & (US$ Million)

Table 58. North America Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 59. North America Transdermal Testosterone Sales by Application (2023-2028) & (K Units)

Table 60. North America Transdermal Testosterone Revenue by Application (2017-2022) & (US$ Million)

Table 61. North America Transdermal Testosterone Revenue by Application (2023-2028) & (US$ Million)

Table 62. North America Transdermal Testosterone Sales by Country (2017-2022) & (K Units)

Table 63. North America Transdermal Testosterone Sales by Country (2023-2028) & (K Units)

Table 64. North America Transdermal Testosterone Revenue by Country (2017-2022) & (US$ Million)

Table 65. North America Transdermal Testosterone Revenue by Country (2023-2028) & (US$ Million)

Table 66. Europe Transdermal Testosterone Sales by Company (2017-2022) & (K Units)

Table 67. Europe Transdermal Testosterone Sales Market Share by Company (2017-2022)

Table 68. Europe Transdermal Testosterone Revenue by Company (2017-2022) & (US$ Million)

Table 69. Europe Transdermal Testosterone Revenue Market Share by Company (2017-2022)

Table 70. Europe Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 71. Europe Transdermal Testosterone Sales by Type (2023-2028) & (K Units)

Table 72. Europe Transdermal Testosterone Revenue by Type (2017-2022) & (US$ Million)

Table 73. Europe Transdermal Testosterone Revenue by Type (2023-2028) & (US$ Million)

Table 74. Europe Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 75. Europe Transdermal Testosterone Sales by Application (2023-2028) & (K Units)

Table 76. Europe Transdermal Testosterone Revenue by Application (2017-2022) & (US$ Million)

Table 77. Europe Transdermal Testosterone Revenue by Application (2023-2028) & (US$ Million)

Table 78. Europe Transdermal Testosterone Sales by Country (2017-2022) & (K Units)

Table 79. Europe Transdermal Testosterone Sales by Country (2023-2028) & (K Units)

Table 80. Europe Transdermal Testosterone Revenue by Country (2017-2022) & (US$ Million)

Table 81. Europe Transdermal Testosterone Revenue by Country (2023-2028) & (US$ Million)

Table 82. Asia Pacific Transdermal Testosterone Sales by Company (2017-2022) & (K Units)

Table 83. Asia Pacific Transdermal Testosterone Sales Market Share by Company (2017-2022)

Table 84. Asia Pacific Transdermal Testosterone Revenue by Company (2017-2022) & (US$ Million)

Table 85. Asia Pacific Transdermal Testosterone Revenue Market Share by Company (2017-2022)

Table 86. Asia Pacific Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 87. Asia Pacific Transdermal Testosterone Sales by Type (2023-2028) & (K Units)

Table 88. Asia Pacific Transdermal Testosterone Revenue by Type (2017-2022) & (US$ Million)

Table 89. Asia Pacific Transdermal Testosterone Revenue by Type (2023-2028) & (US$ Million)

Table 90. Asia Pacific Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 91. Asia Pacific Transdermal Testosterone Sales by Application (2023-2028) & (K Units)

Table 92. Asia Pacific Transdermal Testosterone Revenue by Application (2017-2022) & (US$ Million)

Table 93. Asia Pacific Transdermal Testosterone Revenue by Application (2023-2028) & (US$ Million)

Table 94. Asia Pacific Transdermal Testosterone Sales by Region (2017-2022) & (K Units)

Table 95. Asia Pacific Transdermal Testosterone Sales by Region (2023-2028) & (K Units)

Table 96. Asia Pacific Transdermal Testosterone Revenue by Region (2017-2022) & (US$ Million)

Table 97. Asia Pacific Transdermal Testosterone Revenue by Region (2023-2028) & (US$ Million)

Table 98. Latin America Transdermal Testosterone Sales by Company (2017-2022) & (K Units)

Table 99. Latin America Transdermal Testosterone Sales Market Share by Company (2017-2022)

Table 100. Latin America Transdermal Testosterone Revenue by Company (2017-2022) & (US$ Million)

Table 101. Latin America Transdermal Testosterone Revenue Market Share by Company (2017-2022)

Table 102. Latin America Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 103. Latin America Transdermal Testosterone Sales by Type (2023-2028) & (K Units)

Table 104. Latin America Transdermal Testosterone Revenue by Type (2017-2022) & (US$ Million)

Table 105. Latin America Transdermal Testosterone Revenue by Type (2023-2028) & (US$ Million)

Table 106. Latin America Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 107. Latin America Transdermal Testosterone Sales by Application (2023-2028) & (K Units)

Table 108. Latin America Transdermal Testosterone Revenue by Application (2017-2022) & (US$ Million)

Table 109. Latin America Transdermal Testosterone Revenue by Application (2023-2028) & (US$ Million)

Table 110. Latin America Transdermal Testosterone Sales by Country (2017-2022) & (K Units)

Table 111. Latin America Transdermal Testosterone Sales by Country (2023-2028) & (K Units)

Table 112. Latin America Transdermal Testosterone Revenue by Country (2017-2022) & (US$ Million)

Table 113. Latin America Transdermal Testosterone Revenue by Country (2023-2028) & (US$ Million)

Table 114. Middle East and Africa Transdermal Testosterone Sales by Company (2017-2022) & (K Units)

Table 115. Middle East and Africa Transdermal Testosterone Sales Market Share by Company (2017-2022)

Table 116. Middle East and Africa Transdermal Testosterone Revenue by Company (2017-2022) & (US$ Million)

Table 117. Middle East and Africa Transdermal Testosterone Revenue Market Share by Company (2017-2022)

Table 118. Middle East and Africa Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 119. Middle East and Africa Transdermal Testosterone Sales by Type (2023-2028) & (K Units)

Table 120. Middle East and Africa Transdermal Testosterone Revenue by Type (2017-2022) & (US$ Million)

Table 121. Middle East and Africa Transdermal Testosterone Revenue by Type (2023-2028) & (US$ Million)

Table 122. Middle East and Africa Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 123. Middle East and Africa Transdermal Testosterone Sales by Application (2023-2028) & (K Units)

Table 124. Middle East and Africa Transdermal Testosterone Revenue by Application (2017-2022) & (US$ Million)

Table 125. Middle East and Africa Transdermal Testosterone Revenue by Application (2023-2028) & (US$ Million)

Table 126. Middle East and Africa Transdermal Testosterone Sales by Country (2017-2022) & (K Units)

Table 127. Middle East and Africa Transdermal Testosterone Sales by Country (2023-2028) & (K Units)

Table 128. Middle East and Africa Transdermal Testosterone Revenue by Country (2017-2022) & (US$ Million)

Table 129. Middle East and Africa Transdermal Testosterone Revenue by Country (2023-2028) & (US$ Million)

Table 130. AbbVie Corporation Information

Table 131. AbbVie Description and Overview

Table 132. AbbVie Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 133. AbbVie Transdermal Testosterone Product and Services

Table 134. AbbVie Transdermal Testosterone SWOT Analysis

Table 135. AbbVie Recent Developments

Table 136. Teva Corporation Information

Table 137. Teva Description and Overview

Table 138. Teva Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 139. Teva Transdermal Testosterone Product and Services

Table 140. Teva Transdermal Testosterone SWOT Analysis

Table 141. Teva Recent Developments

Table 142. Perrigo Corporation Information

Table 143. Perrigo Description and Overview

Table 144. Perrigo Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 145. Perrigo Transdermal Testosterone Product and Services

Table 146. Perrigo Transdermal Testosterone SWOT Analysis

Table 147. Perrigo Recent Developments

Table 148. Endo Pharmaceuticals Corporation Information

Table 149. Endo Pharmaceuticals Description and Overview

Table 150. Endo Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 151. Endo Pharmaceuticals Transdermal Testosterone Product and Services

Table 152. Endo Pharmaceuticals Transdermal Testosterone SWOT Analysis

Table 153. Endo Pharmaceuticals Recent Developments

Table 154. Acerus Pharmaceuticals Corporation Information

Table 155. Acerus Pharmaceuticals Description and Overview

Table 156. Acerus Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 157. Acerus Pharmaceuticals Transdermal Testosterone Product and Services

Table 158. Acerus Pharmaceuticals Transdermal Testosterone SWOT Analysis

Table 159. Acerus Pharmaceuticals Recent Developments

Table 160. Lupin Corporation Information

Table 161. Lupin Description and Overview

Table 162. Lupin Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 163. Lupin Transdermal Testosterone Product and Services

Table 164. Lupin Transdermal Testosterone SWOT Analysis

Table 165. Lupin Recent Developments

Table 166. Dr. Reddy's Laboratories Corporation Information

Table 167. Dr. Reddy's Laboratories Description and Overview

Table 168. Dr. Reddy's Laboratories Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 169. Dr. Reddy's Laboratories Transdermal Testosterone Product and Services

Table 170. Dr. Reddy's Laboratories Transdermal Testosterone SWOT Analysis

Table 171. Dr. Reddy's Laboratories Recent Developments

Table 172. Upsher-Smith Laboratories Corporation Information

Table 173. Upsher-Smith Laboratories Description and Overview

Table 174. Upsher-Smith Laboratories Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 175. Upsher-Smith Laboratories Transdermal Testosterone Product and Services

Table 176. Upsher-Smith Laboratories Transdermal Testosterone SWOT Analysis

Table 177. Upsher-Smith Laboratories Recent Developments

Table 178. Allergan Corporation Information

Table 179. Allergan Description and Overview

Table 180. Allergan Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 181. Allergan Transdermal Testosterone Product and Services

Table 182. Allergan Transdermal Testosterone SWOT Analysis

Table 183. Allergan Recent Developments

Table 184. Cipla Inc. Corporation Information

Table 185. Cipla Inc. Description and Overview

Table 186. Cipla Inc. Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 187. Cipla Inc. Transdermal Testosterone Product and Services

Table 188. Cipla Inc. Transdermal Testosterone SWOT Analysis

Table 189. Cipla Inc. Recent Developments

Table 190. Key Raw Materials Lists

Table 191. Raw Materials Key Suppliers Lists

Table 192. Transdermal Testosterone Distributors List

Table 193. Transdermal Testosterone Customers List

Table 194. Research Programs/Design for This Report

Table 195. Key Data Information from Secondary Sources

Table 196. Key Data Information from Primary Sources

List of Figures

Figure 1. Transdermal Testosterone Product Picture

Figure 2. Global Transdermal Testosterone Sales Market Share by Type in 2021 & 2028

Figure 3. Gel Product Picture

Figure 4. Patch Product Picture

Figure 5. Global Transdermal Testosterone Sales Market Share by Application in 2021 & 2028

Figure 6. Primary Hypogonadism Use Case

Figure 7. Hypogonadotropic Hypogonadism Use Case

Figure 8. Late-Onset Hypogonadism Use Case

Figure 9. Transdermal Testosterone Report Years Considered

Figure 10. Global Transdermal Testosterone Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Transdermal Testosterone Market Size 2017-2028 (US$ Million)

Figure 12. Global Transdermal Testosterone Sales (2017-2022) & (K Units)

Figure 13. Global Transdermal Testosterone Market Size Market Share by Region: 2021 VS 2028

Figure 14. Global Transdermal Testosterone Sales Market Share by Region (2017-2022)

Figure 15. Global Transdermal Testosterone Sales Market Share by Region in 2021

Figure 16. Global Transdermal Testosterone Revenue Market Share by Region in 2017 VS 2021

Figure 17. Global Transdermal Testosterone Sales Share by Manufacturers in 2021

Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Testosterone Sales in 2021

Figure 19. Transdermal Testosterone Revenue Share by Manufacturers in 2021

Figure 20. Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 21. Global Transdermal Testosterone Revenue Share by Type (2017-2022)

Figure 22. Global Transdermal Testosterone Revenue Growth Rate by Type in 2017 & 2021

Figure 23. Global Transdermal Testosterone Revenue Share by Application (2017-2022)

Figure 24. Global Transdermal Testosterone Revenue Growth Rate by Application in 2017 & 2021

Figure 25. North America Transdermal Testosterone Sales Market Share by Type (2017-2028)

Figure 26. North America Transdermal Testosterone Revenue Market Share by Type (2017-2028)

Figure 27. North America Transdermal Testosterone Sales Market Share by Application (2017-2028)

Figure 28. North America Transdermal Testosterone Revenue Market Share by Application (2017-2028)

Figure 29. North America Transdermal Testosterone Sales Share by Country (2017-2028)

Figure 30. North America Transdermal Testosterone Revenue Share by Country (2017-2028)

Figure 31. U.S. Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 32. Canada Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 33. Europe Transdermal Testosterone Sales Market Share by Type (2017-2028)

Figure 34. Europe Transdermal Testosterone Revenue Market Share by Type (2017-2028)

Figure 35. Europe Transdermal Testosterone Sales Market Share by Application (2017-2028)

Figure 36. Europe Transdermal Testosterone Revenue Market Share by Application (2017-2028)

Figure 37. Europe Transdermal Testosterone Sales Share by Country (2017-2028)

Figure 38. Europe Transdermal Testosterone Revenue Share by Country (2017-2028)

Figure 39. Germany Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 40. France Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 41. U.K. Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 42. Italy Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 43. Russia Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 44. Asia Pacific Transdermal Testosterone Sales Market Share by Type (2017-2028)

Figure 45. Asia Pacific Transdermal Testosterone Revenue Market Share by Type (2017-2028)

Figure 46. Asia Pacific Transdermal Testosterone Sales Market Share by Application (2017-2028)

Figure 47. Asia Pacific Transdermal Testosterone Revenue Market Share by Application (2017-2028)

Figure 48. Asia Pacific Transdermal Testosterone Sales Share by Region (2017-2028)

Figure 49. Asia Pacific Transdermal Testosterone Revenue Share by Region (2017-2028)

Figure 50. China Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 51. Japan Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 52. South Korea Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 53. India Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 54. Australia Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 55. Taiwan Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 56. Indonesia Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 57. Thailand Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 58. Malaysia Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 59. Philippines Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 60. Vietnam Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 61. Latin America Transdermal Testosterone Sales Market Share by Type (2017-2028)

Figure 62. Latin America Transdermal Testosterone Revenue Market Share by Type (2017-2028)

Figure 63. Latin America Transdermal Testosterone Sales Market Share by Application (2017-2028)

Figure 64. Latin America Transdermal Testosterone Revenue Market Share by Application (2017-2028)

Figure 65. Latin America Transdermal Testosterone Sales Share by Country (2017-2028)

Figure 66. Latin America Transdermal Testosterone Revenue Share by Country (2017-2028)

Figure 67. Mexico Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 68. Brazil Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 69. Argentina Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 70. Middle East and Africa Transdermal Testosterone Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Transdermal Testosterone Revenue Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Transdermal Testosterone Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Transdermal Testosterone Revenue Market Share by Application (2017-2028)

Figure 74. Middle East and Africa Transdermal Testosterone Sales Share by Country (2017-2028)

Figure 75. Middle East and Africa Transdermal Testosterone Revenue Share by Country (2017-2028)

Figure 76. Turkey Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 77. Saudi Arabia Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 78. UAE Transdermal Testosterone Revenue (2017-2028) & (US$ Million)

Figure 79. Transdermal Testosterone Value Chain

Figure 80. Transdermal Testosterone Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5600

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Transdermal Testosterone Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published Date: September 2022

Report Code: QYRE-Auto-20Q12037

Global Transdermal Testosterone Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

FEATURED COMPANIES

Transdermal Testosterone Segment by Type

Transdermal Testosterone Segment by Application

FEATURED COMPANIES

RELATED REPORTS